| Chondroitin sulfate (n = 97) | Celecoxib (n = 97) |
---|---|---|
Female | 53 (54.6) | 61 (62.9) |
Age (years) | 61.4 ± 9.3 | 61.3 ± 8.5 |
Body mass index (kg/m2) | 30.1 ± 5.8 | 32.3 ± 5.8 |
At least one previous medical condition | 86 (88.7) | 86 (88.7) |
At least one active medical condition | 96 (99.0) | 97 (100.0) |
Cartilage volume (mm3) | ||
 Lateral compartment | 4613 ± 1755 | 4405 ± 1157 |
  Condyle | 2621 ± 1073 | 2476 ± 716 |
  Plateau | 1993 ± 799 | 1930 ± 540 |
 Medial compartment | 4515 ± 1537 | 4255 ± 1217 |
  Condyle | 2807 ± 971 | 2646 ± 779 |
  Plateau | 1708 ± 623 | 1609 ± 489 |
Synovial membrane thickness (mm) | 1.0 ± 0.2 | 1.0 ± 0.2 |
BML score (global knee)a | 2.6 ± 3.0 | 2.7 ± 2.5 |
Synovial fluid volume (ml) | 13.8 ± 14.6 | 10.8 ± 10.9 |
Joint swelling and effusion | ||
  Swelling | 76 (78.4) | 78 (80.4) |
  Effusion | 76 (78.4) | 71 (73.2) |
  Both | 59 (60.8) | 55 (56.7) |
Pain VAS (mm)a | 62.42 ± 15.51 | 59.26 ± 18.10 |
WOMACa | ||
  Total score (0–240) | 124.9 ± 38.1 | 126.7 ± 43.9 |
  Pain score (0–50) | 25.6 ± 8.1 | 25.5 ± 9.0 |
  Stiffness score (0–20) | 10.8 ± 3.7 | 11.7 ± 4.3 |
  Physical function score (0–170) | 88.5 ± 28.7 | 89.5 ± 32.5 |
Quality of life (SF-36)a | ||
  Physical component summary | 35.4 ± 7.8 | 35.7 ± 8.1 |
  Mental component summary | 51.7 ± 9.5 | 52.7 ± 11.0 |